London, UK--(Marketwire - June 14, 2007) -

                        2nd ANNUAL HEALTH CARE CONFERENCE

LONDON, UK, 14 June 2007-- SkyePharma PLC (LSE: SKP) announces today that the Company's Chief Operating Officer, Dr Ken Cunningham, will make a presentation at the Piper Jaffray 2nd Annual Health Care Conference in London. Dr Cunningham will deliver his presentation on Thursday 21 June 2007 at 2.40 p.m. Investors may access a live webcast of the presentation at under the Investor Relations tab. The presentation will be archived for 3 months.

For further information please contact:

SkyePharma PLC                      Frank Condella      +44 20 7491 1777
                                    Ken Cunningham
                                       Peter Grant

Financial Dynamics (UK Enquiries)      David Yates      +44 20 7831 3113
                                     Deborah Scott

Trout Group (US Enquiries)       Christine Labaree      +1 617 583 1308
                                        Seth Lewis

About SkyePharma PLC

Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and life-cycle extension. The Company has eleven approved products in the areas of oral, inhalation and topical delivery that are marketed throughout the world by leading pharmaceutical companies.

For more information, visit

                      This information is provided by RNS
            The company news service from the London Stock Exchange